Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,223 | -25,777 | -65,782 | -46,239 | -31,105 |
| Depreciation Amortization | 972 | 494 | 1,737 | 1,305 | 869 |
| Accounts receivable | 3,775 | 423 | 2,651 | -217 | 5,443 |
| Accounts payable and accrued liabilities | N/A | 152 | N/A | 1,303 | N/A |
| Other Working Capital | 3,531 | 923 | 9,327 | 2,145 | 5,311 |
| Other Operating Activity | 2,397 | 4,132 | 10,924 | 11,079 | 1,288 |
| Operating Cash Flow | $-33,548 | $-19,653 | $-41,143 | $-30,624 | $-18,194 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,681 | 15,962 | -64,326 | -7,045 | -9,197 |
| PPE Investments | -221 | -35 | -316 | -213 | -24 |
| Investing Cash Flow | $17,460 | $15,927 | $-64,642 | $-7,258 | $-9,221 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,450 | -1,725 | N/A | N/A | N/A |
| Common Stock Issued | 736 | 268 | 135,581 | 134,991 | 48,818 |
| Other Financing Activity | -37 | -19 | 122 | 139 | 0 |
| Financing Cash Flow | $-2,751 | $-1,476 | $135,703 | $135,130 | $48,818 |
| Beginning Cash Position | 53,568 | 53,568 | 23,650 | 23,650 | 23,650 |
| End Cash Position | 34,729 | 48,366 | 53,568 | 120,898 | 45,053 |
| Net Cash Flow | $-18,839 | $-5,202 | $29,918 | $97,248 | $21,403 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,548 | -19,653 | -41,143 | -30,624 | -18,194 |
| Capital Expenditure | -221 | -35 | -328 | -213 | -24 |
| Free Cash Flow | -33,769 | -19,688 | -41,471 | -30,837 | -18,218 |